Registration
WILEY REIN LLP for FRESENIUS KABI USA LLC
Firm
Client
Income
—
Expenses
—
What was lobbied
One issue area, each in the filer's own words, with who lobbied on it and where.
Pharmacy PHA
H.R. 3269/S. 2276, Eliminating Thickets to Increase Competition (ETHIC) Act; H.R. 6485/S. 43, Skinny Labels, Big Savings Act; Biosimilar industry issues
| Lobbyist | Covered position, as disclosed |
|---|---|
| KARIN HESSLER New | — |
Foreign entities
Foreign owners and affiliates the filer disclosed. Amounts are as declared on this filing.
| Entity | Country | Principal place of business | Ownership | Contribution declared |
|---|---|---|---|---|
| FRESENIUS KABI SWISSBIOSIM GMBH | Switzerland | Switzerland | 100.0% | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.